NHS Cancer Programme Innovation Open call 2 Selection panel
Professor Ruth Plummer (Chair)
Clinical Professor of Experimental Cancer Med at Newcastle University
Expertise: Early phase cancer trials and drug development, pharmacokinetic and pharmacodynamic biomarker analysis. Treatment of skin cancers.
Dr Neville Young (Deputy Chair)
Director of Enterprise & Innovation at Yorkshire and Humber Academic Health Science Network
Expertise: Innovative surgical tools, intraoperative imaging, biosensors, nanotechnology.
Dr Sarah Byron
Programme Director, Devices, Diagnostics and Digital
Expertise: Assessment of the clinical and cost effectiveness of devices, diagnostics and digital technologies and developing NICE guidance for NHS Strategic leadership Stakeholder engagement and management.
Professor Paula Ghaneh
Professor at University of Liverpool
Expertise: Pancreatic surgeon, research interests are diagnosis and treatment of pancreatic cancer, clinical trials.
Professor John Hutton
Independent expert
Expertise: Health Economics; Economic Evaluation of Health Technologies.
Professor David Jayne
Professor of Surgery at University of Leeds
Expertise: Development and clinical translation of new surgical technologies, including early and late phase clinical trials.
Dr Rosie Loftus
Chief Medical Officer at Macmillan Cancer Support
Expertise: Previously GP principal. Previously led Macmillan cancer support primary care community.
Dr Sonja Marjanovic
Director – Healthcare Innovation, Industry and Policy at RAND Europe
Expertise: Dr Marjanovic’s expertise lies in healthcare innovation policy, implementation research, quality improvement research and evaluation of innovation and service improvement interventions.
Professor Steven Morris
Founder & CEO at Ingram Networks Ltd
Expertise: Prof Morris was co-founder of Creo Medical Ltd. His experience includes growing small companies, fund-raising, management of R&D and securing regulatory approvals.
Miss Claire O’Rourke
Managing Director at The Christie NHS Foundation Trust
Expertise: Managing Director of the Greater Manchester Cancer Alliance, cancer transformation and performance.
Professor Shonit Punwani
Professor of Magnetic Resonance and Cancer Imaging at University College London
Consultant Radiologist at UCL Hospitals
Expertise: Prof Punwani is the Director of Clinical Imaging at UCLH Biomedical Research Centre and has extensive experience in radiology, MRI and provision of imaging services.
Mr Nishan Sunthares
Managing Director – Diagnostics at Association of British Healthtech Industries
Experienced HealthTech business leader with strong understanding of the broad diagnostics (IVD, imaging, endoscopy, genomics) market, commercial knowledge, health system policy, and government working.
Mr Naser Turabi
Director of Evidence and Implementation at Cancer Research UK
Expertise: Naser leads CRUK’s work on evidence review, social and behavioural research, cancer data analysis and health systems engagement. Previously he was an NHS Cancer Alliance Managing Director and has many years experiences as a management consultant, social researcher and NHS manager.
Mrs Elaine Warburton
Board Director at QuantuMDx Group Ltd
Expertise: Commercial Biotech and healthcare Board Director with specialism in innovation within the fields of diagnostics and early detection and treatment of infectious diseases and cancer.
Mrs Helen George
PPIE Representative
Expertise: Formerly Projects Manager at East Sussex Fire Service. MSc Human Centred Computer Systems (Sussex). Currently assistant for special needs childrens’ transport. PPI member of i4i panel.
Dr John David Marshall
PPIE Representative
Expertise: Dr Marshall has been a PPI for a number of cancer charities and the N W Research for Patient Benefit Committee of NIHR assessing research funding applications.